Violation Tracker Parent Company Summary

Parent Company Name: 
Takeda Pharmaceutical
Ownership Structure: 
publicly traded
Headquartered in: 
Japan
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,333,531,447
Number of records: 
23
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
government-contracting-related offenses$1,246,349,91010
healthcare-related offenses$56,500,0002
competition-related offenses$24,911,3675
employment-related offenses$4,750,0001
environment-related offenses$600,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$1,246,349,91010
off-label or unapproved promotion of medical products$56,500,0002
price-fixing or anti-competitive practices$23,513,3673
wage and hour violation$4,750,0001
kickbacks and bribery$1,398,0002
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Primary Offense Type Year Agency Penalty Amountsort icon
TAP Pharmaceutical Products Inc. False Claims Act and related 2001 DOJ_CIVIL $875,000,000
Shire Pharmaceuticals LLC False Claims Act and related 2017 DOJ_CIVIL $350,000,000
Shire Pharmaceuticals LLC off-label or unapproved promotion of medical products 2014 FDA $56,500,000
TAP Pharmaceutical Products, Inc. False Claims Act and related 2001 MULTI-AG (*) $25,516,440
Shire Pharmaceuticals LLC off-label or unapproved promotion of medical products 2014 MULTI-AG (*) $20,786,034
Takeda Chemical price-fixing or anti-competitive practices 2000 MULTI-AG $17,551,650
Shire Pharmaceuticals LLC False Claims Act and related 2017 MULTI-AG (*) $6,104,000
Takeda Chemical price-fixing or anti-competitive practices 2000 CA-AG $5,850,550
Takeda Pharmaceuticals U.S.A. False Claims Act and related 2019 IL-AG $5,833,333
TAP Pharmaceutical Products False Claims Act and related 2011 PA-AG $5,240,797
Baxalta US Inc. wage and hour violation 2019 private lawsuit-state $4,750,000
Shire False Claims Act and related 2013 LA-AG $4,000,000
Takeda/Tap Pharmaceuticals False Claims Act and related 2013 LA-AG $3,750,000
Takeda Pharmaceuticals False Claims Act and related 2008 AL-AG $2,000,000
TAP Pharmaceutical Products, Inc. kickbacks and bribery 2006 WI-AG $798,000
TAP Pharmaceutical Products, Inc. kickbacks and bribery 2006 KY-AG $600,000
Shire Human Genetic Therapies, Inc. environmental violation 2021 MA-AG $600,000
TAP Pharmaceutical Products, Inc. False Claims Act and related 2001 AR-AG $525,780
TAP Pharmaceutical Products, Inc. consumer protection violation 2006 ID-AG $198,000
BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE workplace safety or health violation 2011 OSHA $195,000
Takeda Chemical price-fixing or anti-competitive practices 2002 MA-AG $111,167
SHIRE PLC workplace safety or health violation 2016 OSHA $19,070
SHIRE CORP workplace safety or health violation 2002 OSHA $8,100
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)